An endocrinologist specializing in thyroid cancer and creator of the Hemoglobin A1c test for diabetes reflects on his career, offering advice for aspiring researchers.

Increasingly, scientists like those at the Rogel Cancer Center are using 3-D cell cultures to more closely model cancer cells in the body.

The analysis highlights the diversity of immune response in pancreatic cancer, and points toward the need for treatments tailored to individual patients.

The U-M-led development and validation of a staging system for non-metastatic prostate cancer could help doctors and patients assess treatment options, as well as improve clinical trials.

Researchers have demonstrated that a new liquid biopsy approach overcomes traditional barriers to quickly and efficiently diagnose and monitor high-grade gliomas.

This phase 2 trial also identified a subset of patients with specific mutations who may see the most benefit from the drug.